Document is current
Any future updates will be listed below
-
Authors
Costa, N
Gombault, E
Marcélo, C
Pagès, A
Molinier, L
de Souto Barreto, P
Rolland, Y
-
Funding
Funding for this research was provided by:
Inspire Chair of Excellence of Pfizer
- License Information
-
More Information
Article History
Received: 23 February 2024
Accepted: 8 April 2025
First Online: 1 May 2025
Declarations
:
: The INCUR study was conducted in accordance with the amended Declaration of Helsinki. Both the Ethics Committee of the “[Blinded for review]” University Hospital and the Consultative Committee for the Treatment of Research Information on Health (CNIL) approved the study protocol (approval number: “[DR- 2012 - 291."]”). The requirement for informed consent was waived by the Ethics Committee of (Committee for the protection of People (CPP)) because of the retrospective nature of the study. All patients (or their representatives) received written information about the study prior to inclusion and could decline participation.
: Not applicable.
: The authors declare no competing interests.
